NFKB1 and lymphoma: There is a high-frequency set of mutated genes in HBsAg-positive DLBCLs that may affect multiple key pathways involved in lymphoma development, such as epigenetic regulation, DNA damage repair, BCR/NF-kB, and immune evasion (Figure 6).